Corcym Announces First-in-Human Implant of TriMemo®, Extending Its Memo Platform to Tricuspid Valve Repair

Corcym announced the first human implant of TriMemo, its purpose-built adaptive tricuspid valve repair device incorporating superelastic Memo technology. The clinical milestone supports validation of the company's structural-heart product innovation, though the release provided no financial, regulatory, or commercial-sales details.